CLINICAL_TRIALS
trial_result
· 2021-01-05
Clinical Trial Update: A Long-Term Study of Rovalpituzumab Tesirine [Phase 2]
Summary
Phase 2 long-term study of rovalpituzumab tesirine completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-01-05